Trial Profile
A Phase 1 Study of Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir as Part of a Neoadjuvant Regimen [fluorouracil + folinic acid + gemcitabine] in Patients With Locally Advanced Pancreatic Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Oct 2023
Price :
$35
*
At a glance
- Drugs Nelfinavir (Primary) ; Fluorouracil; Folinic acid; Gemcitabine
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- 09 Aug 2019 Status changed from active, no longer recruiting to completed.
- 09 Aug 2019 Status changed from active, no longer recruiting to completed.
- 24 Apr 2018 Planned End Date changed from 1 Dec 2013 to 1 Apr 2019.